These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27182202)

  • 1. Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.
    Iriyama N; Yuan B; Hatta Y; Takagi N; Takei M
    Cancer Cell Int; 2016; 16():37. PubMed ID: 27182202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.
    Rashid A; Duan X; Gao F; Yang M; Yen A
    Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
    Congleton J; MacDonald R; Yen A
    Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3.
    Lu H; Weng XQ; Sheng Y; Wu J; Xi HM; Cai X
    BMC Cancer; 2022 Jul; 22(1):749. PubMed ID: 35810308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK.
    Ding M; Weng XQ; Sheng Y; Wu J; Liang C; Cai X
    Food Chem Toxicol; 2018 Sep; 119():464-478. PubMed ID: 29097117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
    Congleton J; Shen M; MacDonald R; Malavasi F; Yen A
    Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
    Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
    Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines.
    Hussain AM; Lee HC; Chang CF
    Eur J Cell Biol; 2000 Oct; 79(10):697-706. PubMed ID: 11089918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells.
    Lainey E; Wolfromm A; Sukkurwala AQ; Micol JB; Fenaux P; Galluzzi L; Kepp O; Kroemer G
    Cell Cycle; 2013 Sep; 12(18):2978-91. PubMed ID: 23974111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells.
    Makishima M; Honma Y
    Leuk Res; 1996 Sep; 20(9):781-9. PubMed ID: 8947589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bromodomain Inhibitor JQ1 Enhances the Responses to All-
    Kang C; Kim CY; Kim HS; Park SP; Chung HM
    Int J Stem Cells; 2018 May; 11(1):131-140. PubMed ID: 29699387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells.
    Li ZY; Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Lu H; Cai X
    Am J Transl Res; 2020; 12(12):7836-7854. PubMed ID: 33437364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.
    Redner RL; Beumer JH; Kropf P; Agha M; Boyiadzis M; Dorritie K; Farah R; Hou JZ; Im A; Lim SH; Raptis A; Sehgal A; Christner SM; Normolle D; Johnson DE
    Leuk Lymphoma; 2018 Nov; 59(11):2595-2601. PubMed ID: 29616864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.
    Kazim N; Yen A
    Cell Cycle; 2021 Dec; 20(24):2638-2651. PubMed ID: 34836491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vibsanin A sensitizes human acute myeloid leukemia cells to tyrosine kinase inhibitor-induced myeloid differentiation via activation of PKC and upregulation of Lyn.
    Shen X; Xing S; Zhang L; Wang F; Ou H; Shan Y; Xiao H; Xiong G; Wang X; Zhao Q; Cong Y; Yu Z
    Biochem Biophys Res Commun; 2018 Jul; 502(1):110-115. PubMed ID: 29787755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
    Huang Q; Wang L; Ran Q; Wang J; Wang C; He H; Li L; Qi H
    Drug Des Devel Ther; 2019; 13():1927-1940. PubMed ID: 31239643
    [No Abstract]   [Full Text] [Related]  

  • 19. Trametinib enhances ATRA-induced differentiation in AML cells.
    Lu H; Li ZY; Ding M; Liang C; Weng XQ; Sheng Y; Wu J; Cai X
    Leuk Lymphoma; 2021 Dec; 62(14):3361-3372. PubMed ID: 34355652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
    Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
    Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.